menu
    • menu

    Company profile for XOMA

    NEW Drugs in Dev: 9
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company’s portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas. Many of these licenses are the result of XOMA’s pioneering efforts in the discovery and development of antibody therapeutics. The Compa...
    XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company’s portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas. Many of these licenses are the result of XOMA’s pioneering efforts in the discovery and development of antibody therapeutics. The Company’s royalty-aggregator business model includes acquiring additional licenses to programs with third-party funding.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    XOMAUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2200 Powell Street, Suite 310 Emeryville, CA 94608 (510) 204-7200
    Telephone
    Telephone
    (510) 204-7200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.xoma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xoma/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/xomacorp

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    XOMA Royalty To Present At Investor Conferences In March
    XOMA Royalty To Present At Investor Conferences In March

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240650/7281/en/XOMA-Royalty-to-Present-at-Investor-Conferences-in-March.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    XOMA Royalty Announces CFO Transition
    XOMA Royalty Announces CFO Transition

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216767/7281/en/XOMA-Royalty-Announces-CFO-Transition.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    XOMA Royalty, Takeda Strike Mezagitamab Royalty Deal
    XOMA Royalty, Takeda Strike Mezagitamab Royalty Deal

    30 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/30/3211329/7281/en/XOMA-Royalty-and-Takeda-Execute-Strategic-Royalty-Sharing-Transaction-and-Amend-Existing-Agreement-for-Mezagitamab.html

    GLOBENEWSWIRE
    30 Dec 2025
    Share Share
    XOMA Royalty Enters Into Agreement To Acquire Generation Bio
    XOMA Royalty Enters Into Agreement To Acquire Generation Bio

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205887/0/en/XOMA-Royalty-Enters-into-Agreement-to-Acquire-Generation-Bio.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    XOMA Royalty Completes Acquisition Of Mural Oncology
    XOMA Royalty Completes Acquisition Of Mural Oncology

    05 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/05/3200742/7281/en/XOMA-Royalty-Announces-Closing-of-Transaction-to-Acquire-Mural-Oncology-plc.html

    GLOBENEWSWIRE
    05 Dec 2025
    Share Share
    XOMA Royalty Reveals 2025 Q3 Financials & Business Milestones
    XOMA Royalty Reveals 2025 Q3 Financials & Business Milestones

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186116/7281/en/XOMA-Royalty-Reports-Third-Quarter-and-Year-to-Date-2025-Financial-Results-and-Highlights-Recent-Business-Achievements.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact XOMA and get a quotation

    XOMA is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find a price of CELL LINE (SOURCE, HISTORY AND GENERATION ) FOR SCH 900105 CONCENTRATE FOR INJECTION bulk offered by XOMA

    Find a price of XOMA 3AB bulk offered by XOMA

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search